Added to YB: 2024-03-07
Pitch date: 2024-03-06
GLTO [bullish]
Galecto, Inc.
+43.82%
current return
Author Info
Turtles all the way down! is a newsletter that shares short pitches on cheap stocks from all around the world. Sign up for their newsletter
Company Info
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
Market Cap
$35.6M
Pitch Price
$22.25
Price Target
2.67 (-92%)
Dividend
N/A
EV/EBITDA
-2.49
P/E
-2.24
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Turtles Added to Portfolio Holding: Galecto, Inc.
$GLTO CEO incentivized to sell co. soon; thinks 6/30/24 co. will be in better place. Otto sees $50-200M for IP. At $50M & 30% disc, 200% up. Pessimistic $15M burn, cash ~stock price. Even $10M proceeds & $20M burn, limited downside. Potential multi-bagger, but base is protected.
Read full article (2 min)